ArticleBeilstein journal of nanotechnology2026
Electrochemical determination of ciprofloxacin using a MIL-101/reduced graphene oxide-modified electrode.
Article in Beilstein journal of nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An electrochemical sensor for the determination of ciprofloxacin (CPR) was developed using a glassy carbon electrode modified with MIL-101/reduced graphene oxide (MIL-101/rGO). MIL-101/rGO was synthesized via a facile ultrasonic-assisted method and characterized by various physicochemical techniques. The synergistic combination of MIL-101 with rGO significantly enhanced the electrocatalytic activity toward CPR oxidation. The electrochemical behavior of CPR on the MIL-101/rGO-modified electrode was systematically investigated using cyclic voltammetry and differential pulse voltammetry. Under optimized experimental conditions, the proposed sensor exhibited a linear response over 0.25-9.41 µM and a detection limit of 0.11 µM for CPR determination. The sensor also demonstrated good selectivity, satisfactory repeatability, and long-term stability. Furthermore, the method's practical applicability was validated by the determination of CPR in pharmaceutical samples, yielding acceptable recoveries. These results indicate that the MIL-101/rGO-modified electrode provides a promising and efficient platform for the electrochemical sensing of CPR in pharmaceutical and environmental analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.